Average Co-Inventor Count = 5.27
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (53 from 4,958 patents)
2. Basilea Pharmaceutica Ag (1 from 72 patents)
3. C4 Therapeutics, Inc. (1 from 33 patents)
4. F. Hoffmann-La Roche Ag (169 patents)
5. Fontana-Hunziker Gmbh (0 patent)
55 patents:
1. 12509467 - CGAS inhibiting triazolopyrimidone derivatives
2. 12486253 - Therapeutics for the degradation of mutant BRAF
3. 12116349 - Methylquinazolinone derivatives
4. 11673888 - Bicyclic compounds as ATX inhibitors
5. 11352330 - Phenoxymethyl derivatives
6. 11098048 - Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
7. 11059794 - Heterocyclic compounds useful as dual ATX/CA inhibitors
8. 10913745 - Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
9. 10889588 - Bicyclic compounds as dual ATX/CA inhibitors
10. 10882857 - Bicyclic compounds as ATX inhibitors
11. 10849881 - Octahydro-cyclobuta[1,2-c;3,4-c']dipyrrol-2-yl
12. 10800786 - Bicyclic compounds as ATX inhibitors
13. 10787459 - Bicyclic compounds as ATX inhibitors
14. 10738053 - Bicyclic compounds as dual ATX/CA inhibitors
15. 10676446 - Bicyclic quinazolinone derivatives